Investor Presentation - First Six Months of 2021
26
Investor presentation
First six months of 2021
Sales growth of 12% at CER, driven by IO sales growth of 13%
and 11% sales growth in NAO
Historic & reported sales by geography
Reported sales and growth breakdown
for the first six months of 2021
Novo Nordisk®
Sales in DKK billion
107.9
126.9
66.8
Regions
Sales
(MDKK)
Growth
Share of
growth
8%
14%
15%
9%
International Operations
36,984
13%
58%
11%
12%
EMEA
19,109
11%
27%
30%
27%
29%
Region China
8,052
12%
11%
ROW
9,823
16%
20%
North America Operations
29,861
11%
42%
53%
48%
45%
Here of USA
27,926
10%
39%
Total sales
66,845
12%
100%
2015
2020
YTD 2021
North America
EMEA
China
ROW
IO: International Operations; NAO: North American Operations; EMEA: Europe, Middle East, and Africa; Row: Rest of World; Region China covers mainland China, Hong Kong and Taiwan.
Note: Numbers may not add up to 100% due to rounding; Growth at Constant exchange rates; Sales numbers are reported in Danish kronerView entire presentation